Colorectal Cancer Profiler Next

What is Colorectal cancer profiler next test?

Colorectal cancer profiler next test is an advanced Next Generation Sequencing (NGS) panel designed to analyze multiple genes commonly mutated in colorectal cancer (CRC). It tests for somatic mutations in tumor tissue, identifying changes driving colorectal cancer growth. This test includes key actionable genes like KRAS, NRAS, BRAF, PIK3CA, and others. This panel is critical & helps understand the molecular profile of the tumor to guide treatment decisions.

Why consider Colorectal cancer profiler next test?

• To identify mutations that predict response or resistance to targeted therapies (e.g., anti-EGFR drugs).
• To guide personalized treatment and clinical management.
• To stratify patients for prognosis and therapy selection.
• To find targetable mutations for clinical trials or emerging therapies.

Who should get tested for Colorectal cancer profiler next test?

• Patients diagnosed with colorectal adenocarcinoma (especially metastatic).
• Patients being considered for targeted therapy or immunotherapy.
• Oncologists planning precision oncology approaches for CRC patients.
• Patients with therapy-resistant tumors where molecular insights may inform next steps.

More Information

OTHER NAMES: CRC Molecular Profiling Panel, Colorectal Tumor Mutation Panel, Somatic Mutation Analysis for CRC, Colorectal Cancer NGS Panel

Colorectal cancer is a type of cancer that starts in the colon or rectum, parts of the large intestine. It usually begins as benign growths called polyps which can become cancerous over time. CRC is one of the most common cancers worldwide. Early detection improves survival significantly. Diagnosis involve Colonoscopy, Fecal occult blood test (FOBT) or fecal immunochemical test (FIT), CT scans, MRI for staging and Molecular tests (e.g., COLORECTAL CANCER PROFILER NEXT) to detect mutations for personalized therapy.